SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,058 | -99.5% | 100 | -97.5% | 0.00% | -100.0% |
| Q3 2019 | $422,000 | -10.0% | 3,932 | +53.4% | 0.00% | -50.0% |
| Q2 2019 | $469,000 | +29.9% | 2,563 | +13.0% | 0.00% | +100.0% |
| Q1 2019 | $361,000 | +71.1% | 2,269 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $211,000 | +0.5% | 2,200 | +64.2% | 0.00% | 0.0% |
| Q2 2018 | $210,000 | +2525.0% | 1,340 | +1240.0% | 0.00% | – |
| Q2 2017 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $7,000 | +40.0% | 100 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -16.7% | 100 | -18.0% | 0.00% | – |
| Q3 2016 | $6,000 | -93.5% | 122 | -96.1% | 0.00% | -100.0% |
| Q2 2016 | $93,000 | +3000.0% | 3,100 | +3000.0% | 0.00% | – |
| Q1 2016 | $3,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |